| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/13/1999 | CN1041631C Novel carbocyclic nucleoside agents useful as selective inhititors of proinflammatory cell factor |
| 01/12/1999 | US5859271 Inhibitors of phospholipase that prevent phospholipase mediated injury, injury due to oxidation, and inflammation; side effect reduction |
| 01/12/1999 | US5859257 Isoxazole compounds as cyclooxygenase inhibitors |
| 01/12/1999 | US5859253 Metalloproteinase inhibitors |
| 01/12/1999 | US5859244 1,4-dihydropyridine derivatives and methods of producing the same |
| 01/12/1999 | US5859240 Reduction of imine group; oxidation; salt formation |
| 01/12/1999 | US5859229 For inhibition of gene expression of human cyclooxygenase 2 by binding to specific untranslated regions of messenger rna; treatment of premature labor, preeclampsia, endometriosis, rheumatoid arthritis |
| 01/12/1999 | US5859201 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/12/1999 | US5859067 Preparing bis(2-hydroxy-1-naphthyl)decane from the corresponding diacid; forming acid dichloride; treating with 2-naphthol; rearrangement; reduction; inhibits action of adenosine triphosphatase |
| 01/12/1999 | US5859062 Guanylhydrazones and their use to treat inflammatory conditions |
| 01/12/1999 | US5859056 Synergistic |
| 01/12/1999 | US5859055 Administering one or both of linolenic and dihomo-g-linolenic acids |
| 01/12/1999 | US5859041 Substituted imidazoles having cytokine inhibitory activity |
| 01/12/1999 | US5859036 Antiinflammatory agents, analgesics |
| 01/12/1999 | US5859034 Tri-substituted phenyl compounds which have useful pharmaceutical activity |
| 01/12/1999 | US5859029 Heterocyclic compounds method of preparing them and pharmeutical compositions in which they are present |
| 01/12/1999 | US5859015 N-heterocyclic piperazinyl and H-heterocyclic piperazinonyl inhibitors of farnesyl-protein transferase |
| 01/12/1999 | US5859012 Inhibitors of farnesyl-protein transferase |
| 01/12/1999 | US5859011 Dihydropyridine derivatives as bradykinin antagonist |
| 01/12/1999 | US5859006 Tetracyclic derivatives; process of preparation and use |
| 01/12/1999 | US5858994 Carbohydrate conjugates as inhibitors of cell adhesion |
| 01/12/1999 | US5858983 Inhibiting binding of cell bearing selectin protein to molecule or cell bearing sialyl-lewis x determinant by contacting with antibody bearing said determinant |
| 01/12/1999 | US5858972 Cyclic peptide |
| 01/12/1999 | US5858718 Pcr a |
| 01/12/1999 | US5858716 H2CAA71 polynucleotides |
| 01/12/1999 | US5858684 Contacting recombinant cell with test compound which is not verapamil or gallopamil, determining ability of compound to affect activities of inorganic ion receptor; determination of agonist and antagonist drugs |
| 01/12/1999 | US5858400 Co-administering an agent having large liposomes that include phospholipids substantially free of sterol |
| 01/12/1999 | CA2103825C 17-hydroxyiminomethyl-5.beta., 14.beta.-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same |
| 01/08/1999 | CA2236473A1 Novel pcra |
| 01/07/1999 | WO1999000420A1 Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
| 01/07/1999 | WO1999000406A1 CYCLIC AGONISTS AND ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS |
| 01/07/1999 | WO1999000383A1 Eprosartan monohydrate |
| 01/07/1999 | WO1999000379A1 4-[(1h-imidazol-4-yl)piperidin-1-yl]anilide derivatives, their preparation and application in therapy |
| 01/07/1999 | WO1999000361A1 Ace-inhibitor nitric salts |
| 01/07/1999 | WO1999000353A1 Novel thyroid receptor ligands and method |
| 01/07/1999 | WO1999000132A1 Use of phospholamban inhibitors for increasing coronary flow |
| 01/07/1999 | WO1999000128A1 Antithrombotic agents |
| 01/07/1999 | WO1999000116A2 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 01/07/1999 | WO1999000115A1 Use of antagonists or partial agonists of the vanilloid receptor complexes for treating neurodegenerative diseases |
| 01/07/1999 | WO1999000015A1 Method of enhancing magnesium absorption and prevention of atherosclerosis |
| 01/07/1999 | WO1998045427A3 Insulin-like growth factor agonist peptides |
| 01/07/1999 | WO1998044893A3 Method and formulation for treating vascular disease |
| 01/07/1999 | EP0889129A2 GidA1 polypeptides from Staphylococcus aureus |
| 01/07/1999 | EP0889127A1 Serine/threonine protein kinase (H-SGK2) |
| 01/07/1999 | EP0889126A2 YNL075W/HTXFT19 polypeptide |
| 01/07/1999 | EP0889123A2 MurC gene of Staphylococcus aureus coding for UDP-N-acetylmuramate:L-alanine Ligase |
| 01/07/1999 | EP0889031A1 Simple process for producing high-quality captopril |
| 01/07/1999 | EP0888452A2 Extracellular matrix signalling molecules |
| 01/07/1999 | EP0888374A1 High affinity nucleic acid ligands of complement system proteins |
| 01/07/1999 | EP0888373A1 Smooth muscle cell lim protein |
| 01/07/1999 | EP0888358A1 Piperidine derivatives |
| 01/07/1999 | EP0888357A1 Azaspiro derivatives |
| 01/07/1999 | EP0888356A1 Condensed 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors |
| 01/07/1999 | EP0888350A1 Azolobenzazepine derivatives as neurologically active agents |
| 01/07/1999 | EP0888344A1 Spirocycle integrin inhibitors |
| 01/07/1999 | EP0888341A1 Novel sulphur derivatives comprising an amide bond, method for preparing same, use thereof as drugs, and pharmaceutical compositions containing such derivatives |
| 01/07/1999 | EP0888340A1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 01/07/1999 | EP0888335A1 Novel pyrimidine compounds useful in treating cytokine mediated diseases |
| 01/07/1999 | EP0888333A1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 01/07/1999 | EP0888327A1 Benzopyran derivatives having leukotriene-antagonistic action |
| 01/07/1999 | EP0888324A1 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof |
| 01/07/1999 | EP0888319A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 01/07/1999 | EP0888317A1 Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma |
| 01/07/1999 | EP0888313A1 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors |
| 01/07/1999 | EP0888310A1 Cinnoline derivatives and use as medicine |
| 01/07/1999 | EP0888309A1 Imidazole derivatives having affinity for alpha2 receptors activity |
| 01/07/1999 | EP0888299A1 Sulphur derivatives with a retroamide bond as endothelin-converting enzyme inhibitors |
| 01/07/1999 | EP0888298A2 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 01/07/1999 | EP0888278A1 Antidiabetic agents |
| 01/07/1999 | EP0888123A2 Antagonism of endothelin actions |
| 01/07/1999 | EP0888115A1 Iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 01/07/1999 | DE19728524A1 Cyclische Azapeptide Cyclic Azapeptide |
| 01/07/1999 | CA2765222A1 Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| 01/07/1999 | CA2295925A1 Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
| 01/07/1999 | CA2295089A1 Use of antagonists or partial agonists of the vanilloid receptor complexes for treating neurodegenerative diseases |
| 01/07/1999 | CA2294550A1 Use of phospholamban inhibitors for increasing coronary flow |
| 01/07/1999 | CA2294240A1 Antithrombotic agents |
| 01/07/1999 | CA2294232A1 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 01/07/1999 | CA2292794A1 Ace-inhibitor nitric salts |
| 01/06/1999 | CN1204326A Arylethenesulfonamide derivatives and drug composition containing the same |
| 01/06/1999 | CN1204315A New phenylamidine derivatives process for preparing the same and their use as medicaments |
| 01/06/1999 | CN1203948A Promoter of human endoglin gene and its use |
| 01/06/1999 | CN1041524C Oligopeptides derived from C-reactive protein fragments and its medical composition |
| 01/05/1999 | US5856574 Ortho-subsituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 01/05/1999 | US5856564 Condensed benzazepine derivative and pharmaceutical composition thereof |
| 01/05/1999 | US5856509 Hypotensive agents |
| 01/05/1999 | US5856503 Anticholesterol agents |
| 01/05/1999 | US5856484 Sulfonylaminopyrimidine carboxylic acid derivatives having endothelin inhibiting activity |
| 01/05/1999 | US5856463 PSKH-1 ribozymes |
| 01/05/1999 | US5856448 Materials involved in the control of the cardiovascular system, and in particular to activities mediated by thrombin and its cellular receptor. |
| 01/05/1999 | US5856360 Pharmaceutical method for the treatment of severe blood loss and for the inhibition or treatment of hemorrhagic shock |
| 01/05/1999 | US5856358 Prevent bone erosion |
| 01/05/1999 | US5856354 Tachykinin antagonists |
| 01/05/1999 | US5856346 Short-acting dihydropyridines |
| 01/05/1999 | US5856344 Sulfonylamino-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic aid, and medicament containing them |
| 01/05/1999 | US5856338 Sulfonamide-substituted compounds, processes for their preparation, their use as a medicament or diagnostic, and pharmaceutical preparation comprising them |
| 01/05/1999 | US5856336 Anticholesterol agents |
| 01/05/1999 | US5856330 Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin |
| 01/05/1999 | US5856316 Mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses |
| 01/05/1999 | US5856297 Human C3b/C4b receptor (CR1) |